NCT07420738

Brief Summary

This prospective study aims to compare the effects of minimal invasive extracorporeal circulation (MiECC) and conventional reservoir-based extracorporeal circulation techniques on cerebral perfusion in patients undergoing elective coronary artery bypass graft (CABG) surgery. Although the adverse effects of cardiopulmonary bypass on cerebral perfusion and oxygenation are well recognized, the relationship between these effects and changes in intracranial pressure has not been fully elucidated. In this context, ultrasonographic measurement of optic nerve sheath diameter (ONSD), a non-invasive surrogate marker of intracranial pressure, will be used in combination with near-infrared spectroscopy (NIRS) to enable a comprehensive assessment of cerebral perfusion and oxygenation. Between February 2026 and February 2027, a total of 70 ASA II-III patients scheduled for elective CABG surgery will be prospectively enrolled and allocated according to the extracorporeal circulation technique used. Perioperative ONSD measurements will be performed by a single anesthesiologist blinded to the perfusion technique. The primary endpoint is the comparison of perioperative changes in ONSD between the two techniques. Secondary endpoints include the correlation between ONSD and NIRS values, incidence of cerebrovascular events, extubation time, duration of intensive care unit and hospital stay, perioperative hemodynamic parameters, and postoperative complications. This study is expected to provide clinically relevant data on the cerebral effects of different extracorporeal circulation strategies and contribute to perioperative neuromonitoring practices in cardiac surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
12mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
May 2026May 2027

First Submitted

Initial submission to the registry

February 4, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 19, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 4, 2026

Last Update Submit

February 11, 2026

Conditions

Keywords

İntracranial pressureoptic nerve sheath diameter

Outcome Measures

Primary Outcomes (1)

  • Perioperative Optic Nerve Sheath Diameter (ONSD)

    Perioperative changes in optic nerve sheath diameter will be measured using ultrasonography to evaluate the effects of different extracorporeal circulation techniques on intracranial pressure-related cerebral perfusion.

    Before initiation of cardiopulmonary bypass (CPB), during CPB, and immediately after completion of CPB (within the intraoperative period).

Secondary Outcomes (6)

  • Cerebral Oxygenation (NIRS)

    From before induction of anesthesia through the intraoperative period until completion of anesthesia.

  • Correlation Between ONSD and NIRS

    Correlation analysis performed using intraoperative ONSD and NIRS measurements obtained before CPB, during CPB, and after CPB within the intraoperative period

  • Incidence of Cerebrovascular Events

    From completion of surgery to the occurrence of a postoperative cerebrovascular event or hospital discharge, whichever occurred first, assessed up to 30 postoperative days

  • Extubation Time

    From completion of surgery to successful tracheal extubation in the intensive care unit, assessed up to 30 postoperative days.

  • Duration of Mechanical Ventilation

    From completion of surgery to successful tracheal extubation in the intensive care unit, assessed up to 30 postoperative days.

  • +1 more secondary outcomes

Study Arms (2)

Minimal Invasive Extracorporeal Circulation (MiECC) Group

Patients undergoing elective coronary artery bypass graft surgery using a minimal invasive extracorporeal circulation system. Cerebral perfusion will be assessed perioperatively using ultrasonographic optic nerve sheath diameter measurements and near-infrared spectroscopy monitoring.

Conventional Extracorporeal Circulation (cECC) Group

Patients undergoing elective coronary artery bypass graft surgery using a conventional reservoir-based extracorporeal circulation system. Perioperative cerebral perfusion will be evaluated using ultrasonographic optic nerve sheath diameter measurements and near-infrared spectroscopy monitoring.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients aged 18 years and older with American Society of Anesthesiologists (ASA) physical status II-III who are scheduled to undergo elective coronary artery bypass graft surgery with the use of extracorporeal circulation. All participants will be treated according to standard clinical practice in a tertiary cardiac surgery center and will provide written informed consent prior to enrollment.

You may qualify if:

  • Age ≥ 18 years
  • Scheduled for elective coronary artery bypass graft (CABG) surgery
  • American Society of Anesthesiologists (ASA) physical status II-III
  • Planned use of extracorporeal circulation during surgery
  • Ability to provide written informed consent

You may not qualify if:

  • Age \< 18 years
  • ASA physical status other than II-III
  • Emergency surgery
  • Pregnancy
  • History of neurological disease affecting consciousness or decision-making capacity
  • History of psychiatric disease affecting decision-making capacity
  • History of head trauma within the previous 24 hours
  • Presence of carotid artery stenosis or significant carotid artery disease
  • Coagulation disorders (INR \> 1.25, aPTT \> 35 s, or platelet count \< 100,000/μL)
  • Reoperation (redo cardiac surgery)
  • Congestive heart failure
  • Chronic kidney failure
  • Sepsis
  • Hypoxia
  • Ocular trauma
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kosuyolu High Specialization Training and Research Hospital

Istanbul, 34870, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Intracranial Hypertension

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Mustafa Burgaç

    mustafaburgac@outlook.com

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mustafa Burgaç, himself

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist physician

Study Record Dates

First Submitted

February 4, 2026

First Posted

February 19, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

February 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data collected during this study will not be shared. Aggregate study results may be presented in publications. Additional documents such as the study protocol or statistical analysis plan may be made available upon reasonable request to the corresponding author, in accordance with institutional and journal policies.

Locations